Last reviewed · How we verify

NCT03420066

The NEXUS™ Compassionate Use Data Collection Study

Completed Last updated 5 January 2024
What this trial tests

trial testing Retrospective data collection in Aortic Arch Aneurysm in 7 participants. Completed in 28 November 2023.

Timeline
19 February 2018
Primary endpoint
14 September 2018
28 November 2023

Quick facts

Lead sponsorEndospan Ltd.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment7
Start date19 February 2018
Primary completion14 September 2018
Estimated completion28 November 2023
Sites4 locations across Italy, New Zealand, Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Endospan Ltd.

Who can join

Eligibility, any sex, with Aortic Arch Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Multicenter, observational Data Collection Study to Evaluate the Safety and Performance of the Nexus™ Aortic Arch Stent Graft System in patients that were implanted with the device as part of Compassionate Use Procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Retrospective data collection

Trials testing the same drug.

Other recruiting trials for Aortic Arch Aneurysm

Currently open trials in the same condition.

Other Endospan Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03420066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing